31 Mar 2021
Assets833.79
Total Income1,783.67
Profit After Tax-15.35
NET Worth487.06
Total Borrowing141.70
Open 9th Feb 2024 · Close 13th Feb 2024 · Listing 16th Feb 2024
Entero Healthcare Solutions is a Mainboard IPO with an issue size of ₹1,600.00 crore, proposed for listing on BSE, NSE. The offer opens on 9th Feb 2024 and closes on 13th Feb 2024. The issue structure includes a fresh issue of ₹1,000.31 crore and an offer-for-sale component of ₹599.69 crore. The current listing schedule points to 16th Feb 2024.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 11 | ₹13,838 |
| Object | Amount |
|---|---|
| Repayment/prepayment, in full or part, of certain borrowings availed of by our Company | ₹142.50 Cr |
| Funding of long-term working capital requirements of the Company and its Subsidiaries during Fiscals 2025 and 2026 | ₹480.00 Cr |
| General corporate purposes | ₹91.70 Cr |
| Pursuing inorganic growth initiatives through acquisitions | ₹237.00 Cr |
| Total | ₹951.20 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Price to Book Value |
| Expense | Amount |
|---|---|
| BRLMs fees and commissions (including underwriting commission) | ₹40.59 Cr |
| Brokerage, selling commission, bidding charges, processing fees and bidding charges for the Members of the Syndicate, Registered Brokers, SCSBs, RTAs and CDPs | ₹2.24 Cr |
| Advertising and marketing expenses for the Offer | ₹7.60 Cr |
| Other expenses | — |
| Listing fees, SEBI filing fees, BSE & NSE processing fees, book building software fees | ₹4.38 Cr |
| Other regulatory expenses | ₹0.54 Cr |
| Printing and stationery expenses | ₹2.14 Cr |
| Fees payable to the Registrar to the Offer | — |
| Fees payable to the legal counsel | ₹10.14 Cr |
| Miscellaneous, if any | ₹10.31 Cr |